Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72e2a023c558b51d973e979033b70490 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_716283b4d47c7564eba0b73a2e3c1704 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-008 |
filingDate |
1999-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2001-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_594ec8c954c8b9cd49b98e1e1720aef9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d27b4e6bb86235ece5496bb64a2a81b1 |
publicationDate |
2001-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2164117-C2 |
titleOfInvention |
Method for treating secondary glaucoma cases |
abstract |
FIELD: medicine. SUBSTANCE: method involves carrying out ciliary body contraction from the side of posterior chamber using YAG-laser. Erbium-YAG endolaser radiation is applied. The ciliary body is fixed to sclera with endolaser coagulation device. EFFECT: high quantity anatomic adjacency of ciliary body to sclera; reduced risk of ciliary body and vascular eye coat detachment. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2447868-C2 |
priorityDate |
1999-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |